EUVIMEDEUVIMED entdecken
Open Access

Nanopore Protein Sequencing Achieves Significant New Milestones

Brian C Searle iD

Clinical Chemistry · 2024

DOI: 10.1093/clinchem/hvae041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Brian C Searle. Beteiligte Einrichtung: Department of Biomedical Informatics, The Ohio State University Medical Center, Columbus, OH, United States. Hauptthemen laut MEDLINE: Nanopore Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nanopore SequencingHumansSequence Analysis, ProteinProteinsNanopores

Substanzen

Proteins

Autor:innen und Institutionen

  • Department of Biomedical Informatics, The Ohio State University Medical Center, Columbus, OH, United States.
  • Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
  • Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, United States.

ORCID-Profile: Brian C Searle

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • NIH

Zitieren

APA

Searle, B. C. (2024). Nanopore Protein Sequencing Achieves Significant New Milestones. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae041

Vancouver

Searle BC. Nanopore Protein Sequencing Achieves Significant New Milestones. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae041

BibTeX
@article{Searle2024,
  author = {Searle, Brian C},
  title = {Nanopore Protein Sequencing Achieves Significant New Milestones},
  journal = {Clinical Chemistry},
  year = {2024},
  doi = {10.1093/clinchem/hvae041}
}
Kostenlos starten →